30 Nov 2014

EBE and ESCHER launched new project ‘Pharmacovigilance of biologics’

Escher, the TI Pharma platform for regulatory innovation, launched a new project,‘Pharmacovigilance of biologics’ in November 2014. It will address the challenges of product and batch traceability...

Read more
13 Nov 2014


Booklet Annex ...

Read more
11 Jul 2014

EBE Welcomes the Second Innovative Medicines Initiative – A message from Roberto Gradnik

(Brussels, 11 July 2014) Dear all, I had the pleasure of attending this weeks launch event of, the Innovative Medicines Initiative (IMI)2 and delighted to share with you the good new...

Read more
05 Jun 2014

EBE comments on quality guideline (EMA/CHMP/BWP/247713/2012)

In June 2014, EMA published the final version of the Quality guidelines, following approval by Committee for Medicinal Products for Human Use (CHMP) at the end of May 2014.  14 stakeholders submitted comments. European Biopharmaceutical Enterprises (EBE), stakeholder No 5, of a total of 43 comments, 25 were accepted / partly accepted / acknowledged, while some 18 were not accepted....

Read more
02 Apr 2014

Biopharmaceutical SMEs convene to discuss funding strategies

Last week, on 27 March 2014, 65 SMEs and stakeholders in Biopharmaceutical Innovation met to discuss public funding strategies for small companies at a workshop in Brussels organised by European Biopharmaceutical Enterprises, EBE, and European Biotechnology Network, EBN, two organisations that support SME-driven life science development....

Read more
27 Sep 2013

EMA – European Medicines Agency organising workshop on biosimilars

The European Medicines Agency is holding a workshop on biosimilars on 31 October 2013 in London. The Agency is organising this workshop as part of its public-consultation exercise on its three draft revised overarching guidelines on biosimilars....

Read more
15 Aug 2013

World health report 2013: Research for universal health coverage

The main purpose of the report is to provide countries, donor agencies, international organizations and others with the information they need to help them make policy and funding decisions. The report is also offered to a wider audience, from universities, teaching hospitals and schools, to journalists and the public at large - anyone, in fact, with a professional or personal interest in international health issues....

Read more
13 Aug 2013

Speaker presentations slides from CMC Strategy Forum Europe 2013

The EBE BioManufacturing WG organised a Satellite Workshop at the CASSS CMC Strategy Forum Europe on 6 May 2013....

Read more
24 Jul 2013

EFPIA and PhRMA Release Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients

EFPIA and PhRMA have jointly developed a set of industry principles for sharing clinical trial data. The press release underneath summarises these commitments....

Read more
09 Jul 2013

Priority Medicines for Europe and the World

On Tuesday 9th of July, the 2013 Report Priority Medicines for Europe and the World, produced by the World Health Organisation with financial and technical assistance from the European Commission, was launched in Brussels....

Read more
1 5 6 7 8